Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
Aleksandra Synowiec, Artur Szczepański, Emilia Barreto-Durán, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 2
Open Access | Times Cited: 183

Showing 1-25 of 183 citing articles:

Neutralizing antibodies for the prevention and treatment of COVID-19
Lanying Du, Yang Yang, Xiujuan Zhang
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2293-2306
Open Access | Times Cited: 119
Xuanfei Baidu Decoction reduces acute lung injury by regulating infiltration of neutrophils and macrophages via PD-1/IL17A pathway
Yuying Wang, Xi Wang, Yixuan Li, et al.
Pharmacological Research (2022) Vol. 176, pp. 106083-106083
Open Access | Times Cited: 88
SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains
Peter Radvák, Hyung‐Joon Kwon, Martina Košíková, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 94
Rapid field determination of SARS-CoV-2 by a colorimetric and fluorescent dual-functional lateral flow immunoassay biosensor
Han Han, Chongwen Wang, Xingsheng Yang, et al.
Sensors and Actuators B Chemical (2021) Vol. 351, pp. 130897-130897
Open Access | Times Cited: 81
Follow-Ups on Persistent Symptoms and Pulmonary Function Among Post-Acute COVID-19 Patients: A Systematic Review and Meta-Analysis
Qiuyue Long, Jiwei Li, Xiaoyi Hu, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 74
A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant
Mengxin Zhang, Ying Liang, Dongsheng Yu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 2, pp. 889-900
Open Access | Times Cited: 60
Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies
Francisco Carmona-Torre, Ane Mínguez‐Olaondo, A. López-Bravo, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 55
Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks
Raphael Nyaruaba, Caroline Mwaliko, David Dobnik, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 52
The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses
André Schreiber, Dorothee Viemann, Jennifer Schöning, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 1
Open Access | Times Cited: 48
Cognitive impairment after long COVID-19: current evidence and perspectives
Zhitao Li, Zhen Zhang, Zhuoya Zhang, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 38
The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment
Man Wang, Yuan Zhang, Chunmei Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Extracellular Vimentin as a Target Against SARS‐CoV‐2 Host Cell Invasion
Łukasz Suprewicz, Maxx Swoger, Sarthak Gupta, et al.
Small (2021) Vol. 18, Iss. 6
Open Access | Times Cited: 55
Purification and characterization of the receptor‐binding domain of SARS‐CoV‐2 spike protein from Escherichia coli
Yunxia He, Jinming Qi, Lucheng Xiao, et al.
Engineering in Life Sciences (2021) Vol. 21, Iss. 6, pp. 453-460
Open Access | Times Cited: 49
SARS-CoV-2 Clinical Outcome in Domestic and Wild Cats: A Systematic Review
Sebastian Giraldo-Ramírez, Santiago Rendón-Marín, Javier A. Jaimes, et al.
Animals (2021) Vol. 11, Iss. 7, pp. 2056-2056
Open Access | Times Cited: 46
Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target
Endeshaw Chekol Abebe, Teklie Mengie Ayele, Zelalem Tilahun Muche, et al.
Biologics (2021) Vol. Volume 15, pp. 143-152
Open Access | Times Cited: 42
Dengue and COVID-19: two sides of the same coin
Gathsaurie Neelika Malavige, Chandima Jeewandara, Graham S. Ogg
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 35
Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach
Lu Lu, Leping Liu, Rong Gui, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Persistent Lung Injury and Prothrombotic State in Long COVID
Mengqi Xiang, Haijiao Jing, Chengyue Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection
Bang M. Tran, Samantha L. Grimley, Julie McAuley, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 835-835
Open Access | Times Cited: 28
SARS-CoV-2 infection impairs NK cell functions via activation of the LLT1-CD161 axis
Marzena Lenart, Magdalena Górecka, M. Bochenek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Development of a Fluorescent Immunochromatographic Assay Based on Quantum Dot-Functionalized Two-Dimensional Monolayer Ti3C2 MXene Nanoprobes for the Simultaneous Detection of Influenza A Virus and SARS-CoV-2
Ye Liu, Yue Lv, Wenji Chen, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 30, pp. 35872-35883
Closed Access | Times Cited: 16
Analysis of COVID-19 Infection and Mortality Among Patients With Psychiatric Disorders, 2020
Antônio Lúcio Teixeira, Trudy Millard Krause, Lopita Ghosh, et al.
JAMA Network Open (2021) Vol. 4, Iss. 11, pp. e2134969-e2134969
Open Access | Times Cited: 36
Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections
Katina D. Hulme, Ellesandra C. Noye, Kirsty R. Short, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 33
Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in Chronic Obstructive Pulmonary Disease
Jaspreet Osan, Sattya N. Talukdar, Friederike Feldmann, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 27
Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis
Yiling J. Cheng, Chiao-Hsuan Chao, Yen‐Chung Lai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top